Please Wait
Applying Filters...

Annual Sales of Hyoscine N-Butyl Bromide reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 1,346Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Buscopan

PharmaCompass
Left Arrow
Right Arrow

01

Brand Name : Buscopan

arrow
Saudi International Expo
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Hyoscine Butylbromide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2019 Revenue in Millions : 206

2018 Revenue in Millions : 211

Growth (%) : -3

Sanofi Company Banner

02

Brand Name : Buscopan

arrow
Saudi International Expo
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Hyoscine Butylbromide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 214

2019 Revenue in Millions : 229

Growth (%) : -6

Sanofi Company Banner

03

Brand Name : Buscopan

arrow
Saudi International Expo
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Hyoscine Butylbromide

Main Therapeutic Indication : Anti-Inflammatory

Currency : USD

2018 Revenue in Millions : 219

2017 Revenue in Millions : 216

Growth (%) : 2%

Sanofi Company Banner

04

Brand Name : Buscopan

Hyoscine Butylbromide

arrow
Saudi International Expo
Not Confirmed

Brand Name : Buscopan

arrow
Saudi International Expo
Not Confirmed

Hyoscine Butylbromide

Main Therapeutic Indication : Anti-Inflammatory

Currency : USD

2016 Revenue in Millions : 250

2015 Revenue in Millions : 236

Growth (%) : 6

blank

05

Brand Name : Buscopan

butylscopolamin

arrow
Saudi International Expo
Not Confirmed